The drug remdesivir significantly reduces the time it takes for COVID-19 patients to recover, as compared with a placebo ...
Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the ...
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results